SCHEMBL20511580

SCHEMBL20511580

CC(=O)O[C@@H](C)C(=O)O[C@@H](C)C(=O)O[C@@H](C)C(=O)OC(C)C(=O)O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.46
CHRM2 P08172 1/20 0.35
CHRM4 P08173 1/20 0.35
CHRM1 P11229 1/20 0.35
TBXA2R P21731 1/20 0.35
SMN1; SMN2 Q16637 2/20 0.34
GALR3 O60755 1/20 0.34
MAPT P10636 1/20 0.34
BLM P54132 1/20 0.34
TDP1 Q9NUW8 2/20 0.33
TP53 P04637 1/20 0.33
ALOX15 P16050 1/20 0.32
HDAC3 O15379 1/20 0.32
HDAC4 P56524 1/20 0.32
HDAC1 Q13547 1/20 0.32
HDAC7 Q8WUI4 1/20 0.32
HDAC2 Q92769 1/20 0.32
HDAC10 Q969S8 1/20 0.32
HDAC11 Q96DB2 1/20 0.32
HDAC8 Q9BY41 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18631703 1.00 TSHR (0.46) TSHRCHRM2CHRM4CHRM1TBXA2R
SCHEMBL19812512 1.00 TSHR (0.46) TSHRCHRM2CHRM4CHRM1TBXA2R
SCHEMBL21631291 1.00 TSHR (0.46) TSHRCHRM2CHRM4CHRM1TBXA2R
SCHEMBL20511564 1.00 TSHR (0.46) TSHRCHRM2CHRM4CHRM1TBXA2R
SCHEMBL21631290 1.00 TSHR (0.46) TSHRCHRM2CHRM4CHRM1TBXA2R
SCHEMBL20511537 1.00 TSHR (0.46) TSHRCHRM2CHRM4CHRM1TBXA2R
SCHEMBL20511565 1.00 TSHR (0.46) TSHRCHRM2CHRM4CHRM1TBXA2R
SCHEMBL20511506 1.00 TSHR (0.46) TSHRCHRM2CHRM4CHRM1TBXA2R
SCHEMBL20511609 1.00 TSHR (0.46) TSHRCHRM2CHRM4CHRM1TBXA2R
SCHEMBL18631661 1.00 TSHR (0.46) TSHRCHRM2CHRM4CHRM1TBXA2R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3600324-A1 DRUGS AND COMPOSITIONS FOR THE TREATMENT OF OCULAR DISORDERS Graybug Vision, Inc. (US) 2020-02-05 EP disclosed
WO-2018175922-A1 DRUGS AND COMPOSITIONS FOR THE TREATMENT OF OCULAR DISORDERS Graybug Vision, Inc. (US) 2018-09-27 WO disclosed